Interactive Brokers Advertisement
Home > Boards > US OTC > Medical - Drugs >

Innovation Pharmaceuticals Inc. (IPIX)

Add IPIX Price Alert      Hide Sticky   Hide Intro
Moderator: LilBigKahuna, BooDog, sox040713, Astavakra, TheHound, Matagordaville
Search This Board: 
Last Post: 6/23/2017 3:40:40 AM - Followers: 721 - Board type: Free - Posts Today: 1

Cellceutix Corporation (CTIX)

has changed its name to

Innovation Pharmaceuticals Inc. (IPIX)

Company Address:
100 Cumming Center, Suite 151-B
Beverly, MA 01915
Phone: 978-236-8717
Fax:  978-921-6564

About Innovation Pharmaceuticals Inc.: 

Headquartered in Beverly, Massachusetts, Innovation Pharmaceuticals is a publicly-traded company under the symbol "IPIX".
Innovation Pharmaceuticals is a clinical stage biopharmaceutical company developing innovative therapies in multiple diseases. Innovation Pharmaceuticals believes it has a world-class portfolio of first-in-class lead drug candidates and is now advancing them toward market approval, while actively seeking strategic partnerships. Innovation Pharmaceuticals' psoriasis drug candidate Prurisol completed a Phase 2 trial and Innovation Pharmaceuticals is nearing completion of a Phase 2b study. Prurisol is a small molecule that acts through immune modulation and PRINS reduction. Innovation Pharmaceuticals' anti-cancer drug Kevetrin successfully concluded a Phase 1 clinical trial at Harvard Cancer Centers' Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center, and Innovation Pharmaceuticals has commenced a Phase 2 study. In the laboratory, Kevetrin has shown to induce activation of p53, often referred to as the "Guardian Angel Gene" due to its crucial role in controlling cell mutations. Innovation Pharmaceuticals is in a Phase 2 clinical trial with its novel compound Brilacidin-OM (a defensin mimetic compound) for the prevention of oral mucositis in patients with head and neck cancer. Interim analysis has shown Brilacidin-OM to have a high potential for prevention of severe oral mucositis. Clinical results are consistent with those seen in an animal model in which the occurrence of severe ulcerative oral mucositis was reduced by more than 94% compared to placebo. Innovation Pharmaceuticals' lead antibiotic, Brilacidin, has completed a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infection, or ABSSSI. Top-line data have shown a single dose of Brilacidin to deliver comparable clinical outcomes to the FDA-approved seven-day dosing regimen of daptomycin. Brilacidin has the potential to be a single-dose therapy for certain multi-drug resistant bacteria ("superbugs"). In an ongoing Phase 2 open label Proof-of-Concept trial, favorable interim results have been observed in the first two cohorts of patients treated with Brilacidin for Ulcerative Proctitis/Ulcerative Proctosigmoiditis (UP/UPS), two types of Inflammatory Bowel Disease (IBD).  Innovation Pharmaceuticals has formed research collaborations with world-renowned research institutions in the United States and Europe, including MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna. More information is available at


Ongoing Human Trials:
Product Pipeline:






Recent News and Press Releases:

SEC Filings (CIK:0001355250):

Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f

Share Structure:  See SEC filing link above for current share structure


Cellceutix IP - Patent Filings:


Publication number US8338454 B2
Publication type Grant
Application number US 12/780,132
Publication date Dec 25, 2012
Filing date May 14, 2010
Priority date May 20, 2009
Also published as CA2762427A1, CN102438612A, EP2432464A2, US20100298374, US20130245062, WO2010135170A2, WO2010135170A3, Less «6 More »
Publication number 12780132, 780132, US 8338454 B2, US 8338454B2, US-B2-8338454, US8338454 B2, US8338454B2
Inventors Krishna Menon
Original Assignee Cellceutix Corporation
Export Citation BiBTeX, EndNote, RefMan
Patent Citations (6), Non-Patent Citations (41), Referenced by (1), Classifications (42)
External Links: USPTO, USPTO Assignment, Espacenet

Investor Relations:

Following is a DAILY chart:


All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CTIX News: Current Report Filing (8-k) 06/07/2017 04:19:05 PM
CTIX News: Quarterly Report (10-q) 05/09/2017 04:09:09 PM
CTIX News: Amended Statement of Ownership (sc 13g/a) 04/28/2017 12:50:45 PM
CTIX News: Bahamas Development Corp. (OTC Pink: BDCI) $2.4 Million in Sales and 10% Quarterly Growth – Issues Guidance 04/17/2017 07:03:27 AM
CTIX News: Current Report Filing (8-k) 03/31/2017 04:25:24 PM
#186742  Sticky Note PsO Efficacy Bar // PASI and sPGA (Otezla slcimmuno 06/21/17 12:56:19 PM
#185133  Sticky Note $IPIX - Innovation Pharmaceuticals' (IPIX) CEO Leo Ehrlich KarinCA 06/09/17 02:29:04 PM
#184437  Sticky Note NO SPLIT. Cellceutix Announces Company Name Change to BooDog 06/07/17 04:40:05 PM
#175709  Sticky Note CTIX Milestones, Clinical Trials, Recent Interviews, Fact Sheets sox040713 03/18/17 06:44:12 PM
#174938  Sticky Note B-UP Due Diligence (Rev. 3/10) sox040713 03/10/17 04:08:53 PM
#186915   How do you know it's a small group sox040713 06/23/17 03:40:40 AM
#186914   If one actually looked at a chart, instead LilBigKahuna 06/22/17 10:27:25 PM
#186913 tombrady12nh 06/22/17 10:27:20 PM
#186912   I'm just hoping after the Kevetrin Ovarian phase djs7 06/22/17 10:21:23 PM
#186911   Petemantx, You asked: georgejjl 06/22/17 10:20:57 PM
#186910   Is there a list of posters and when brucethepotter 06/22/17 10:19:26 PM
#186908   I can understand getting patient waivers, but really JTORENCE 06/22/17 09:09:28 PM
#186907   Great question on how and what management will BioTechMaven 06/22/17 08:54:18 PM
#186904   Thanks BioTech. B for IBD could very well Williamsc 06/22/17 08:26:31 PM
#186903   It's likely an effort from the Italian university KarinCA 06/22/17 08:09:49 PM
#186902   CTIX's daily short sale volumes do not represent TheHound 06/22/17 08:05:00 PM
#186901   What was your reaction to this poster re: petemantx 06/22/17 07:57:39 PM
#186900   Yep IPIX Data hitting real soon To revisit the slcimmuno 06/22/17 07:37:36 PM
#186898   Exciting!! cabel 06/22/17 07:12:41 PM
#186897   Good call! TheDane 06/22/17 07:04:13 PM
#186896   Should we be expecting to see endoscopic photos petemantx 06/22/17 06:50:14 PM
#186895   The conference is a major milestone that kicks BioTechMaven 06/22/17 06:36:47 PM
#186894   Next stop.. 2017 Drug Discovery and Therapy Williamsc 06/22/17 06:26:50 PM
#186893   For those that haven't seen today's poster: KarinCA 06/22/17 06:08:16 PM
#186892   Closed green. All that trash talk about down LilBigKahuna 06/22/17 06:04:50 PM
#186890   wrong septmike09 06/22/17 05:58:37 PM
#186888   FINRA short sales of IPIX AlanC 06/22/17 05:37:29 PM
#186887   Getting more exciting every day we draw closer! Boogity BooDog 06/22/17 04:40:52 PM
#186886   I am very excited about the poster that Jhawker 06/22/17 04:32:10 PM
#186884   $IPIX fka $CTIX new corporate overview: KarinCA 06/22/17 04:12:33 PM
#186883   Another prescient call -- Waverunner1 06/22/17 04:11:12 PM
#186882   Bought some more shares back today cyber -- scottsmith 06/22/17 03:58:07 PM
#186881   Had that observation today too. The dooms brigade BioTechMaven 06/22/17 03:52:50 PM
#186878   No - his job is to server small Amatuer17 06/22/17 03:20:32 PM
#186876   Man this is so good it should be septmike09 06/22/17 02:42:14 PM
#186875   IPIX's new theme song: MXAMDUD 06/22/17 02:40:04 PM
#186871   another week; another lost 10% MXAMDUD 06/22/17 02:25:51 PM
#186866   this naked short covering rally in IPIX is awesome!!!! MXAMDUD 06/22/17 12:23:14 PM
#186860   isn't it great? many cheap shares to purchase. septmike09 06/22/17 11:35:11 AM
#186858   I don't see it happening until we get septmike09 06/22/17 11:14:07 AM
#186857   ok 40%. down 70% in the last year MXAMDUD 06/22/17 10:45:51 AM
#186856   IBB up 9% this week. IPIX down 1.3% TheMonolith 06/22/17 10:45:10 AM
#186855   Could (likely is) the company/Aspire raising modest amounts ericseb2003 06/22/17 10:44:59 AM
#186854   I have a 4k bid out there at ericseb2003 06/22/17 10:43:28 AM
#186853   Here's a pretty decent read for media folks faraifarai 06/22/17 10:43:13 AM
#186852   MXAMDUD, your math skills seems off. Pretty sure taas 06/22/17 10:42:43 AM
#186847   Come on!! This price is total BS- tombrady12nh 06/22/17 10:23:23 AM
#186845   gotta love the $50/IPIX share predictions. MXAMDUD 06/22/17 10:14:38 AM
#186843   For the last week or so it seems TheDane 06/22/17 10:00:58 AM
#186841   called it spot on. down 2%. MXAMDUD 06/22/17 09:30:50 AM
#186840   weak open on tap to .73 or .72. MXAMDUD 06/22/17 09:29:15 AM
#186837   have my sell button ready MXAMDUD 06/22/17 08:56:20 AM
#186836   Heading back to .80s. Are all the nickel TheDane 06/22/17 08:51:59 AM
#186835   Today ----> 2017 European Hematology Association (EHA) Annual Meeting TheHound 06/22/17 08:18:34 AM
#186830   ...ok ...Leo might not be perfect...but give me Justfactsmam 06/22/17 07:48:12 AM